Skip to main content

International Psoriasis Council

International Psoriasis Council
subscribe
4   What's New
Search
International Psoriasis Council
subscribe
Search

Advancing Knowledge. Improving Care.

Digital Health and Psoriasis

IMPROVING ACCESS TO EFFECTIVE TREATMENTS, TIMELY DIAGNOSIS, AND OPTIMAL CARE

Project Description

To date, digital health and telemedicine has been largely focused on “first contact visits.” Psoriasis presents unique challenges, including the need for long-term management. Digital health offers opportunities to develop novel approaches such as exploring artificial intelligence (AI) solutions and the personal management of psoriasis care. IPC convened a working group to establish a road map for how IPC can aid the development and implementation of digital health and telemedicine focused on psoriasis diagnosis and management. he digital health working group, chaired by Andrew Blauvelt and co-chaired by George Han, has completed a global consensus statement regarding telemedicine in psoriasis management, considering cultural and technological differences. Additional activities will include: defining best practices for using telemedicine in treating psoriasis, educating dermatologists on both the opportunities and limitations of telemedicine, and conducting research to understand better the barriers to care based on current reimbursement policies on a global level. 

Project Leaders

Andrew

Blauvelt

,

MD, MBA

Blauvelt Consulting, LLC

Annapolis

,

Maryland

,

United States

IPC Board Member
Bio

George

Han

,

MD, PhD

Zucker School of Medicine at Hofstra/Northwell and Icahn School of Medicine at Mount Sinai

New York

,

New York

,

United States

IPC Councilor
Bio

Working Group Members

  • Daniela Armijo, Chile
  • Kevin Cooper, United States
  • Lucas Galimany, Chile
  • Netsanet Gebeyehu, Ethiopia
  • Paolo Gisondi, Italy
  • Mohammad Huq, Bangladesh
  • Satveer Mahil, United Kingdom
  • Alexander Navarini, Switzerland
  • Lev Pavlovsky, Israel
  • Dharshini Sathishkumar, India
  • Ron Vender, Canada

View more resources on digital health.

MORE

ABSTRACT

During the past few decades, classical in‐person communication has been enriched by opportunities for telemedicine. We are in a learning healthcare environment that takes advantage of the opportunities of telemedicine and in‐person consultations, reconciling the individuality of the patient and his/her psoriasis. A working group of experts in telemedicine was installed by the International Psoriasis Council (IPC) to formulate the opportunities and limitations of telemedicine in the diagnosis and treatment of psoriasis. The working group formulated statements on various aspects of telemedicine according to the nominal group technique to reach a consensus on these statements and explore the variation of opinions. Thirty‐six statements regarding teledermatology and psoriasis were agreed upon by the IPC working group. The value and necessity for the implementation of teledermatology in dermatologic healthcare practices for psoriasis are essential. Management of psoriasis through teledermatology is feasible with a few exceptions. In this communication, the statements are presented and discussed in the context of the available literature, and finally, a call to action by IPC is formulated related to these statements.

Link to article

CLOSE

Subscribe to the IPC Newsletter

We believe that psoriasis patients, no matter where they live in the world, no matter how complex their symptoms, should have access to the best care available to them. Please join us in making this possible.

Name(Required)

What's New

Videos Now Available from the IPC Symposium at SID Chicago

Did you miss the IPC symposium at the 83rd Society for Investigative Dermatology (SID) Annual Meeting? Select session videos are now available. The Arc of Disease Control in Psoriasis: Early Interception – Deep Pathway Blockade – Treatment Failure covered early intervention strategies, treatment selection, immune pathway targeting, PsA prevention, clinical escape, and real-world cases that inform long-term psoriasis care.

WATCH NOW

Wednesday, June 17, 2026

Take Ten: Mio Nakamura – Psoriasis and Mental Health

Depression affects approximately 20% of patients with psoriasis, five times the rate seen in the general population. IPC Jr. Councilor Mio Nakamura, MD, MS, FAAD, walks through the bidirectional relationship between psoriasis and depression, the shared inflammatory pathways driving both conditions, and practical guidance on screening and incorporating multidisciplinary mental health support into psoriasis management.

WATCH NOW

Thursday, June 11, 2026